Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06292221 · ClinicalTrials.gov registry record · NA

Personalized Depression Treatment Supported by Mobile Sensor Analytics

A NA study of Depression, sponsored by UConn Health.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT06292221 is a NA study of Depression that has completed, run by UConn Health. The registered enrollment target is 22 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06292221, a NA study of Depression, has completed, sponsored by UConn Health.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The current best practice guidelines for treating depression call for close monitoring of patients, and periodically adjusting treatment as needed. This present study seeks to develop and investigate an innovative digital system, DepWatch, that leverages mobile health technologies and machine learning tools to provide clinicians objective, accurate, and timely assessment of depression symptoms to assist with their clinical decision making process. Specifically, DepWatch collects sensory data passively from smartphones and wristbands, without any user interaction, and uses simple user-friendly interfaces to collect ecological momentary assessments (EMA), medication adherence and safety related data from patients. The collected data will be fed to machine learning models to be developed in the project to provide weekly assessment of patient symptom levels and predict the trajectory of treatment response over time. The assessment and prediction results are then presented using a graphic interface to clinicians to help them make critical treatment decisions. The main question the present clinical trial aims to answer are as follows: 1. Feasibility of the digital tool, DepWatch, to assist clinicians in depression treatment and inform their clinical decision process 2. Effectiveness of the digital tool, DepWatch, to improve depression treatment outcomes All study participants will carry the DepWatch app on their smartphones and wear a Fitbit provided by the study team during the study period. They will also complete brief questionnaires via the app at specific time intervals throughout the study period.

Conditions Studied

Interventions

  • OTHER A mobile Health (mHealth) tool called 'DepWatch'

Study Locations (1)

Connecticut

  • University of Connecticut Health Center - Farmington

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2024-04-04
Est. Completion 2025-06-08
Phase NA

Sponsor

UConn Health

178 total trials

What the Registry Record Tells You About NCT06292221

The ClinicalTrials.gov registry entry for NCT06292221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which A mobile Health (mHealth) tool called 'DepWatch' is the first listed.

NCT06292221 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06292221 about?

NCT06292221 is a clinical study titled "Personalized Depression Treatment Supported by Mobile Sensor Analytics". The current best practice guidelines for treating depression call for close monitoring of patients, and periodically adjusting treatment as needed. This present study seeks to develop and investigate an innovative digital system, DepWatch, that leverages mobile health technologies and machine learni...

What is the current status of trial NCT06292221?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2024-04-04. Estimated completion is 2025-06-08.

What conditions does trial NCT06292221 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT06292221?

The interventions under investigation include: A mobile Health (mHealth) tool called 'DepWatch' (OTHER).

Who is sponsoring clinical trial NCT06292221?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06292221 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.